This dual binding brings tumor cells into close proximity with autologous T cells, triggers the formation of an immunological synapse and T-cell activation, and initiates a polyclonal T-cell response that is characterized by CD3 clustering, T-cell proliferation, and the release of pore-forming granzyme and perforin [45–47]. This evidence concerns the gene PRF1 and neoplasm.